Stocks and securities in focus
| Security | Change (%) | 1w | 1m ▼ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | - | 3.419% | 167.699% | 225.269% | 111.538% | 152.083% | 159.657% |
| Geron Corp. | 1.300% | -4.975% | 27.044% | 48.189% | 120.325% | 207.736% | 218.589% |
| Sarepta Therapeutics | 29.940% | 29.167% | 26.398% | 30.230% | 69.925% | 127.527% | 31.793% |
| Alnylam Pharmace. | 4.150% | 3.403% | 12.609% | -16.153% | -12.458% | 7.829% | 139.527% |
| Eli Lilly Corp. | 0.100% | 0.816% | 11.808% | 100.679% | 56.742% | 343.041% | 716.979% |
| ImmunityBio Inc. | 8.940% | 22.002% | 8.070% | 162.636% | 43.559% | -41.333% | - |
| AbbVie Inc. | -0.850% | 1.308% | 6.274% | 28.058% | 13.890% | 65.759% | 133.959% |
| Ocular Therapeutix Inc. | 2.780% | 8.454% | 4.018% | 35.417% | 39.418% | -48.684% | 57.406% |
| Fate Therapeutics Inc. | -2.670% | -4.179% | -1.384% | -36.422% | -5.849% | -95.132% | - |
| Novavax Inc. | -0.170% | -2.514% | -4.586% | 93.447% | 193.572% | -91.365% | 167.483% |
| Sage Therapeutics Inc. | 0.860% | -0.200% | -9.375% | -80.188% | -49.975% | -79.251% | - |
| Savara Inc. | -2.260% | -9.424% | -12.183% | 26.277% | -19.907% | 143.662% | 52.490% |
| Inotiv Inc. | -0.610% | -1.220% | -17.766% | -63.514% | -50.610% | - | - |
| Ardelyx Inc. | 3.860% | -2.901% | -19.225% | 63.523% | -0.415% | -4.067% | - |
| Puma Biotechnology Inc. | -1.150% | -4.055% | -27.254% | -11.785% | -28.502% | -67.421% | - |
| Cytomx Therapeutics Inc | 3.610% | -6.337% | -29.453% | -13.305% | -13.181% | -79.934% | - |
| Cardiff Oncology Inc. | -4.380% | -9.091% | -29.556% | 66.667% | 74.772% | -65.152% | -34.286% |
| Brainstorm Cell | -1.290% | -12.876% | -36.380% | -83.241% | 56.034% | -88.544% | - |
| G1 Therapeutics | -1.270% | -10.607% | -44.327% | -3.083% | -15.418% | -87.383% | - |
| Verastem Inc. | -3.290% | -13.450% | -73.571% | 214.726% | -60.795% | -93.933% | - |